Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...

New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

This drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related macular degeneration (nAMD). The US FDA has cleared an investigational new ...

Sight Care is an all-new vision support complex that has become a topic of discussion in the market over the past few ...

Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...

The FDA has cleared its first light-based therapy for dry age-related macular degeneration—which the agency described as ...

LUNA and 4-year OPTIC data, alongside Phase 3 trial design updates, anticipated in Q4 2024- Appointed Jason Mitchell as chief ...

Investigators presented numerous studies into new and developing therapies for diabetic macular edema and age-related macular degeneration that were aimed at reducing the treatment burden.

As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting ...